{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:26:05Z","timestamp":1778891165092,"version":"3.51.4"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T00:00:00Z","timestamp":1441324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0137313","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T17:51:49Z","timestamp":1441389109000},"page":"e0137313","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013"],"prefix":"10.1371","volume":"10","author":[{"given":"Matthias","family":"Im\u00f6hl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,4]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470-511.2000","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"MW Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2807\/esm.10.09.00563-en","article-title":"The epidemiology of severe Streptococcus pyogenes associated disease in Europe","volume":"10","author":"TL Lamagni","year":"2005","journal-title":"Euro Surveill"},{"issue":"11\u201312","key":"ref3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/00365540903179749","article-title":"Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006 to 2007","volume":"41","author":"A Vikerfors","year":"2009","journal-title":"Scand J Infect Dis"},{"issue":"41","key":"ref4","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.41.19988-en","article-title":"Invasive Group A streptococcal disease in Ireland, 2004 to 2010","volume":"16","author":"J Martin","year":"2011","journal-title":"Euro Surveill"},{"issue":"33","key":"ref5","doi-asserted-by":"crossref","first-page":"20556","DOI":"10.2807\/1560-7917.ES2013.18.33.20556","article-title":"Increased incidence of invasive group A streptococcal disease in Ireland, 2012 to 2013","volume":"18","author":"M Meehan","year":"2013","journal-title":"Euro Surveill"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"19785","DOI":"10.2807\/ese.16.05.19785-en","article-title":"Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011","volume":"16","author":"K Zakikhany","year":"2011","journal-title":"Euro Surveill"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"JR Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1586\/14787210.2015.1023292","article-title":"Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies","volume":"13","author":"C Silva-Costa","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"DL Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.39.3.577","article-title":"Erythromycin resistance by ribosome modification","volume":"39","author":"B Weisblum","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1368-7646(98)80212-4","article-title":"Macrolide resistance","volume":"1","author":"B Weisblum","year":"1998","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijantimicag.2011.01.019","article-title":"mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany","volume":"37","author":"C Bley","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","year":"1993","journal-title":"JAMA"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1574-695X.2010.00652.x","article-title":"Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003\u20132007","volume":"58","author":"M Im\u00f6hl","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00215250","article-title":"Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci","volume":"180","author":"A Podbielski","year":"1991","journal-title":"Medical Microbiology and Immunology"},{"key":"ref16","article-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement","year":"2014"},{"key":"ref17","unstructured":"(EUCAST) ECoAST. Breakpoint tables for interpretation of MICs and zone diameters 2014 29.01.2014; (4.0)."},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/32.6.885","article-title":"Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland","volume":"32","author":"H Seppala","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1128\/AAC.43.8.1935","article-title":"Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains","volume":"43","author":"E Giovanetti","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10096-010-0989-9","article-title":"Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland","volume":"29","author":"T Siljander","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/JCM.01312-09","article-title":"Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles","volume":"48","author":"R Meisal","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10096-011-1226-x","article-title":"Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998\u20132009): comparison with non-invasive isolates","volume":"30","author":"M Montes","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/JCM.00513-07","article-title":"emm Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: What has changed in 11 years?","volume":"45","author":"R Creti","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1128\/JCM.01163-06","article-title":"Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level","volume":"44","author":"K Szczypa","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1469-0691.2011.03624.x","article-title":"Invasive group A streptococcal infections in adults, France (2006\u20132010)","volume":"18","author":"C Plainvert","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/JCM.01626-07","article-title":"Clinical and Epidemiological Aspects of Invasive Streptococcus pyogenes Infections in Denmark during 2003 and 2004","volume":"46","author":"B Luca-Harari","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijmm.2013.07.004","article-title":"Changes in Streptococcus pyogenes causing invasive disease in Portugal: evidence for superantigen gene loss and acquisition","volume":"303","author":"A Friaes","year":"2013","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijantimicag.2006.07.005","article-title":"Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel","volume":"28","author":"R Nir-Paz","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.02195-12","article-title":"Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?","volume":"50","author":"AC Bowen","year":"2012","journal-title":"J Clin Microbiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0137313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T12:04:33Z","timestamp":1653134673000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0137313"}},"subtitle":[],"editor":[{"given":"Jose","family":"Melo-Cristino","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,4]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0137313","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,4]]}}}